Procedure | Gateway | Type of stent and diameter | Advantages | Limitations |
---|---|---|---|---|
Transmural endoscopic drainage with plastic stents | • Cystogastrostomy • Cystoduodenostomy | Double-pigtail 7-10 Fr | • Low cost • Easy placement and removal • Active or passive drainage (with or without nasocystic drain) | • Small caliber (increased risk of occlusion and secondary infection) • Often need for multiple stents • Possibility of fluid leak and migration • Poor visibility under fluoroscopy during the procedure |
Transmural endoscopic drainage with FCSEMSs | • Cystogastrostomy • Cystoduodenostomy | Tubular biliary stents 6-10 mm | • Large caliber • Possibility to perform DEN through stent • Prevent fluid leak • Good visibility under fluoroscopy • Haemostatic effect at puncture site | • Cost • Difficult placement • Increased risk of stent migration and delayed bleeding (even for the possibility of GI tract injury) |
Transmural endoscopic drainage with LAMSs | • Cystogastrostomy • Cystoduodenostomy | • AXIOS™, 10-15-20 mm (Boston Scientific, Marlborough, MA, USA) • SPAXUS™, 8-10-16 mm (Taewoong Medical, Gimpo, Korea) • NAGI™, 10-16 mm (Taewoong Medical, Gimpo, Korea) • AixstentⓇ PPS, 10-15 mm (Leufen Medical, Berlin, Germany) • Hanaro stentⓇ, 10 mm (Mi-TECH-Medical Co, Seoul, South Korea) | • Large caliber • Easy placement, even without the need for wire exchange • Easy removal • Possibility to perform DEN through stent • Lower risk of migration • Reduced need for fluoroscopy and nasocystic drain placement | • Cost • Increased risk of suprainfection and bleeding in the early phases (<14 days) |
Transpapillary drainage via ERCP | • Major/minor duodenal papilla | Pancreatic endoprosthesis 5-7 Fr | • Active or passive drainage (with or without nasal drain) • Evidence of pancreatic duct disruption • Considered as an alternative when the distance from the GI wall to the PFC is too large (>10-15 mm) | • Limited use in WOPN with poorly-liquefied necrotic tissue |
Percutaneous endoscopic necrosectomy | • Percutaneous approach | Esophageal, partially or fully-covered SEMS 18-20 mm | • Single or multiport gateway • Possibility to perform DEN even if PFC is located distal from the GI tract • Reduced need of deep sedation | • Preceded by the creation of cutaneous fistula by interventional radiologists • Increased risk of peri-procedural bleeding |